Advertisement

Topics

FDA Guidance On Post-Approval Changes for Drug Substances Closes Regulatory Gap

13:43 EDT 14 Sep 2018 | Elsevier Business Intelligence

FDA’s guidance on post-approval changes for drug substances fills in some of the missing pieces of the regulatory puzzle on...

Original Article: FDA Guidance On Post-Approval Changes for Drug Substances Closes Regulatory Gap

NEXT ARTICLE

More From BioPortfolio on "FDA Guidance On Post-Approval Changes for Drug Substances Closes Regulatory Gap"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...